Prime Minister Trudeau Announces $1.1 Billion for a National COVID-19 Research Strategy
Today, Prime Minister Trudeau announced $1.1 billion in additional funding for a national research strategy to combat COVID-19. The strategy will focus on three main pillars: vaccine research, clinical vaccine trials and expanding testing.
The Prime Minister acknowledged that COVID-19 testing will need to be significantly expanded before the Canadian economy can reopen.
Measures Include:
- $115 million in additional funding for vaccine research.
- $662 million for clinical vaccine trials in Canada.
- $350 million to expand national testing and modeling of COVID-19.
- Creation of the COVID-19 Immunity Task Force, led by Dr. David Naylor, Dr. Catherine Hankins, Dr. Tim Evans, Dr. Theresa Tam, and Dr. Mona Nemer to study issues such as testing, serology, and immunity.
- Over 2 years, 1 million Canadians will be tested as part of the Immunity Task Force work.
Federal Engagement
Consult the Sussex COVID-19 Guide for information on supports made available across the Federal, Provincial and Municipal Governments.
As the details of the programs announced today become available, let Sussex help connect you with the right people in government to help your organization get through these extraordinary times.
For more detail, please reach out to your Sussex representative directly or to the Federal Government Relations Team.
